FDA Import Refusal 1FX-6573334-6/10002/1 — RENATA PHARMA
The FDA refused shipment 1FX-6573334-6/10002/1 from RENATA PHARMA (Bangladesh) on May 8, 2026. The refused product falls under Drugs and Biologics — REVLIMID. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- May 8, 2026
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 61CCE03 REVLIMID
- Charges
- 75